Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.532 USD | -2.39% | +3.44% | +94.87% |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 36.36M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -27M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.9
x | P/E ratio 2025 * |
-1.42
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.75% |
Latest transcript on Brainstorm Cell Therapeutics Inc.
1 day | -2.39% | ||
1 week | +3.44% | ||
Current month | -5.79% | ||
1 month | -18.78% | ||
3 months | +71.50% | ||
6 months | +233.12% | ||
Current year | +94.87% |
Managers | Title | Age | Since |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 07-06-30 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 12-12-22 |
Chief Tech/Sci/R&D Officer | - | 22-05-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 00-09-21 |
Uri Yablonka
BRD | Director/Board Member | 47 | 14-06-05 |
Jacob Frenkel
CHM | Chairman | 81 | 20-03-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.532 | -2.39% | 274,960 |
24-04-24 | 0.545 | +3.81% | 201,949 |
24-04-23 | 0.525 | -2.80% | 169,719 |
24-04-22 | 0.5401 | +1.52% | 367,454 |
24-04-19 | 0.532 | +3.44% | 1,007,163 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+94.87% | 36.36M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.07% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- BCLI Stock